Fluorine Scan of Inhibitors of the Cysteine Protease Human Cathepsin L: Dipolar and Quadrupolar Effects in the π‐Stacking of Fluorinated Phenyl Rings on Peptide Amide Bonds
暂无分享,去创建一个
F. Diederich | B. Kuhn | W. Haap | W. Schweizer | T. Schirmeister | M. Harder | M. Giroud | N. Trapp | Nils Trapp
[1] Wei Zhu,et al. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. , 2016, Chemical reviews.
[2] J. Joyce,et al. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response , 2015, Nature Reviews Cancer.
[3] Manfred Kansy,et al. Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery. , 2015, Journal of medicinal chemistry.
[4] D. Siemann,et al. Cathepsin L targeting in cancer treatment. , 2015, Pharmacology & therapeutics.
[5] M. D. Hill,et al. Applications of Fluorine in Medicinal Chemistry. , 2015, Journal of medicinal chemistry.
[6] F. Diederich,et al. Rebek imide platforms as model systems for the investigation of weak intermolecular interactions. , 2015, Chemistry.
[7] R. Tanzi,et al. Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments. , 2015, Biochemistry.
[8] A. Kuglstatter,et al. Finding the perfect spot for fluorine: improving potency up to 40-fold during a rational fluorine scan of a Bruton's Tyrosine Kinase (BTK) inhibitor scaffold. , 2015, Bioorganic & medicinal chemistry letters.
[9] Lixia Wei,et al. Cathepsin L is involved in proliferation and invasion of ovarian cancer cells. , 2015, Molecular medicine reports.
[10] R. Pandey,et al. Plasma cathepsin L: a prognostic marker for pancreatic cancer. , 2014, World journal of gastroenterology.
[11] Julian E. Fuchs,et al. Matched molecular pair analysis: significance and the impact of experimental uncertainty. , 2014, Journal of medicinal chemistry.
[12] Noriyuki Furuichi,et al. Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties. , 2013, ACS medicinal chemistry letters.
[13] J. Lindholt,et al. Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study. , 2013, Atherosclerosis.
[14] F. Diederich,et al. Optimization of Triazine Nitriles as Rhodesain Inhibitors: Structure–Activity Relationships, Bioisosteric Imidazopyridine Nitriles, and X‐ray Crystal Structure Analysis with Human Cathepsin L , 2013, ChemMedChem.
[15] Wolfgang Guba,et al. β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease. , 2013, Journal of medicinal chemistry.
[16] F. Diederich,et al. Efficient Stacking on Protein Amide Fragments , 2013, ChemMedChem.
[17] K. Kishikawa. Utilization of the Perfluoroarene-Arene Interaction for Stabilization of Liquid Crystal Phases , 2012 .
[18] F. Diederich,et al. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors. , 2012, Organic & biomolecular chemistry.
[19] Martin Stahl,et al. Rationalizing Tight Ligand Binding through Cooperative Interaction Networks , 2011, J. Chem. Inf. Model..
[20] Nobuo Shimma,et al. Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments , 2011, ChemMedChem.
[21] D. Banner,et al. Systematische Untersuchung von Halogenbrücken in Protein‐Ligand‐ Wechselwirkungen , 2011 .
[22] François Diederich,et al. Systematic investigation of halogen bonding in protein-ligand interactions. , 2011, Angewandte Chemie.
[23] F. Diederich,et al. Potent and Selective Inhibition of Cysteine Proteases from Plasmodium falciparum and Trypanosoma brucei , 2010, ChemMedChem.
[24] Hong Zheng,et al. Highly specific heterodimerization mediated by quadrupole interactions. , 2010, Angewandte Chemie.
[25] Knut Baumann,et al. Enzyme kinetics and hit validation in fluorimetric protease assays. , 2010, Current topics in medicinal chemistry.
[26] On the role of the dipole and quadrupole moments of aromatic compounds in the solvation by ionic liquids. , 2009, The journal of physical chemistry. B.
[27] F. Diederich,et al. A fluorine scan of non-peptidic inhibitors of neprilysin: Fluorophobic and fluorophilic regions in an enzyme active site , 2008 .
[28] David O'Hagan,et al. Understanding organofluorine chemistry. An introduction to the C-F bond. , 2008, Chemical Society reviews.
[29] S. Purser,et al. Fluorine in medicinal chemistry. , 2008, Chemical Society reviews.
[30] F. Diederich,et al. Fluorine in Pharmaceuticals: Looking Beyond Intuition , 2007, Science.
[31] Manfred Kansy,et al. A Fluorine Scan at the Catalytic Center of Thrombin: CF, COH, and COMe Bioisosterism and Fluorine Effects on pKa and log D Values , 2006, ChemMedChem.
[32] Martin Stahl,et al. Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.
[33] F. Diederich,et al. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions. , 2004, Organic & biomolecular chemistry.
[34] Paul Seiler,et al. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions. , 2003, Angewandte Chemie.
[35] Bruce E. Smart,et al. Fluorine substituent effects (on bioactivity) , 2001 .
[36] N. Kitteringham,et al. Metabolism of fluorine-containing drugs. , 2001, Annual review of pharmacology and toxicology.
[37] Chu-Young Kim,et al. Contribution of Fluorine to Protein−Ligand Affinity in the Binding of Fluoroaromatic Inhibitors to Carbonic Anhydrase II , 2000 .
[38] Peter A. Kollman,et al. A Ligand That Is Predicted to Bind Better to Avidin than Biotin: Insights from Computational Fluorine Scanning , 2000 .
[39] J. Doyon,et al. The pattern of fluorine substitution affects binding affinity in a small library of fluoroaromatic inhibitors for carbonic anhydrase. , 1999, Organic letters.
[40] J. Trudell. Contributions of dipole moments, quadrupole moments, and molecular polarizabilities to the anesthetic potency of fluorobenzenes. , 1998, Biophysical chemistry.
[41] R. Grubbs,et al. Phenyl–Perfluorophenyl Stacking Interactions: A New Strategy for Supermolecule Construction , 1997 .
[42] Geoffrey W. Coates,et al. Spezifische Phenyl-Perfluorphenyl-Stapelwechselwirkungen: eine neue Strategie zum Aufbau supramolekularer Strukturen† , 1997 .
[43] Some influences of fluorine in bioorganic chemistry , 1997 .
[44] J. Hernández‐Trujillo,et al. Molecular Quadrupole Moments for the Series of Fluoro- and Chlorobenzenes , 1996 .
[45] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[46] J. Siegel,et al. Polar Interactions between Stacked π Systems in Fluorinated 1,8-Diarylnaphthalenes: Importance of Quadrupole Moments in Molecular Recognition† , 1995 .
[47] Franco Cozzi,et al. Polare Wechselwirkungen zwischen gestapelten π‐Systemen in fluorierten 1,8‐Diarylnaphthalinen: Bedeutung des Quadrupolmoments für die molekulare Erkennung , 1995 .
[48] Jeffrey H. Williams,et al. The molecular electric quadrupole moment and solid-state architecture , 1993 .